300725 药石科技
已收盘 08-14 15:00:00
资讯
新帖
简况
8月13日药石科技涨10.64%,银河康乐股票A基金重仓该股
证券之星 · 08-13 16:39
8月13日药石科技涨10.64%,银河康乐股票A基金重仓该股
药石科技涨10.64%,开源证券一个月前给出“买入”评级
证券之星 · 08-13 16:38
药石科技涨10.64%,开源证券一个月前给出“买入”评级
研报掘金丨浙商证券:维持药石科技“买入”评级,订单维持高增,盈利持续优化
格隆汇 · 08-13 14:36
研报掘金丨浙商证券:维持药石科技“买入”评级,订单维持高增,盈利持续优化
药石科技(300725)2026年中报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 08-12 06:04
药石科技(300725)2026年中报简析:营收净利润同比双双增长,盈利能力上升
图解药石科技中报:第二季度单季净利润同比增长37.73%
证券之星 · 08-11
图解药石科技中报:第二季度单季净利润同比增长37.73%
药石科技(300725)披露2026年半年度报告,8月10日股价上涨4.44%
证券之星 · 08-10
药石科技(300725)披露2026年半年度报告,8月10日股价上涨4.44%
药石科技(300725)7月20日股东户数4.65万户,较上期增加11.32%
证券之星 · 08-10
药石科技(300725)7月20日股东户数4.65万户,较上期增加11.32%
药石科技:上半年净利润9944.49万元,同比增长37.17%
格隆汇 · 08-10
药石科技:上半年净利润9944.49万元,同比增长37.17%
药石科技新提交“ZoeCarbon”等2件商标注册申请
证券之星 · 08-10
药石科技新提交“ZoeCarbon”等2件商标注册申请
8月7日药石科技涨18.39%,银河康乐股票A基金重仓该股
证券之星 · 08-07
8月7日药石科技涨18.39%,银河康乐股票A基金重仓该股
药石科技涨18.39%,开源证券一个月前给出“买入”评级
证券之星 · 08-07
药石科技涨18.39%,开源证券一个月前给出“买入”评级
药石科技:将持续通过规范治理、稳健经营、提升信息披露质量和加强投资者沟通等方式,努力推动公司内在价值提升
证券之星 · 08-05
药石科技:将持续通过规范治理、稳健经营、提升信息披露质量和加强投资者沟通等方式,努力推动公司内在价值提升
药石科技:始终坚持自身差异化战略定位
证券之星 · 08-05
药石科技:始终坚持自身差异化战略定位
药石科技涨11.16%,开源证券四周前给出“买入”评级
证券之星 · 08-04
药石科技涨11.16%,开源证券四周前给出“买入”评级
7月30日药石科技跌6.06%,银河康乐股票A基金重仓该股
证券之星 · 07-30
7月30日药石科技跌6.06%,银河康乐股票A基金重仓该股
药石科技:截至2026年7月20日,公司股东人数46,538名
证券之星 · 07-24
药石科技:截至2026年7月20日,公司股东人数46,538名
7月17日药石科技跌11.77%,信澳优享生活混合A基金重仓该股
证券之星 · 07-17
7月17日药石科技跌11.77%,信澳优享生活混合A基金重仓该股
7月14日药石科技创60日新高,信澳优享生活混合A基金重仓该股
证券之星 · 07-14
7月14日药石科技创60日新高,信澳优享生活混合A基金重仓该股
开源证券:给予药石科技买入评级
证券之星 · 07-06
开源证券:给予药石科技买入评级
药石科技(300725)披露调整2026年度日常关联交易预计公告,7月3日股价上涨1.47%
证券之星 · 07-03
药石科技(300725)披露调整2026年度日常关联交易预计公告,7月3日股价上涨1.47%
加载更多
公司概况
公司名称:
南京药石科技股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2017-11-10
主营业务:
南京药石科技股份有限公司的主营业务是提供具备类药性的创新小分子砌块。公司的主要产品是药物研究阶段的产品与服务、药物开发阶段的产品和服务、新分子实体(OPC)业务、绿色与智能技术平台。
发行价格:
11.32
{"stockData":{"symbol":"300725","market":"SZ","secType":"STK","nameCN":"药石科技","latestPrice":54.77,"timestamp":1786691025000,"preClose":54.79,"halted":0,"volume":35651416,"delay":0,"changeRate":-0.0004,"floatShares":202999999,"shares":234000000,"eps":0.9011,"marketStatus":"已收盘","change":-0.02,"latestTime":"08-14 15:00:00","open":54.7,"high":55.55,"low":52.83,"amount":1937000000,"amplitude":0.0496,"askPrice":54.78,"askSize":26,"bidPrice":54.77,"bidSize":156,"shortable":0,"etf":0,"ttmEps":0.9011,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":54.79,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":60.27,"lowLimit":49.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":233807341,"isCdr":false,"pbRate":2.81,"roa":"--","peRate":60.781267,"roe":"1.82%","epsLYR":0.88,"committee":-0.004071,"marketValue":12806000000,"turnoverRate":0.1759,"status":1,"floatMarketCap":11103000000},"requestUrl":"/m/hq/s/300725","defaultTab":"news","newsList":[{"id":"2659324021","title":"8月13日药石科技涨10.64%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659324021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659324021?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:39","pubTimestamp":1786610348,"startTime":"0","endTime":"0","summary":"证券之星消息,8月13日药石科技涨10.64%创60日新高,收盘报54.79元,换手率24.38%,成交量49.42万手,成交额26.15亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.11亿元,最新净值2.486,较上一交易日上涨0.49%,近一年下跌8.97%。银河康乐股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300026913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659281132","title":"药石科技涨10.64%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2659281132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659281132?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:38","pubTimestamp":1786610337,"startTime":"0","endTime":"0","summary":"今日药石科技涨10.64%,收盘报54.79元。2026年7月6日,开源证券研究员余汝意发布了对药石科技的研报《公司信息更新报告:CRDMO转型稳步推进,盈利蓄力增长》,该研报对药石科技给出“买入”评级。研报中预计2026-2028年公司归母净利润为2.49/3.34/4.12亿元,EPS为1.07/1.43/1.76元,当前股价对应PE为35.0/26.2/21.2倍,公司作为国内稀缺的CRDMO一体化平台,2026Q1在手订单超20%增长锁定收入弹性,维持“买入”评级。药石科技个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300026908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659778136","title":"研报掘金丨浙商证券:维持药石科技“买入”评级,订单维持高增,盈利持续优化","url":"https://stock-news.laohu8.com/highlight/detail?id=2659778136","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659778136?lang=zh_cn&edition=full","pubTime":"2026-08-13 14:36","pubTimestamp":1786602988,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0276","601878","BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658573949","title":"药石科技(300725)2026年中报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658573949","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658573949?lang=zh_cn&edition=full","pubTime":"2026-08-12 06:04","pubTimestamp":1786485849,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期药石科技发布2026年中报。截至本报告期末,公司营业总收入10.59亿元,同比上升15.19%,归母净利润9944.49万元,同比上升37.17%。本报告期药石科技盈利能力上升,毛利率同比增幅4.65%,净利率同比增幅19.08%。投资活动产生的现金流量净额变动幅度为105.02%,原因:公司理财产品投资收回及出售部分药捷安康股票取得收益。本文数据来源于药石科技2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200004216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658958009","title":"图解药石科技中报:第二季度单季净利润同比增长37.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658958009","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658958009?lang=zh_cn&edition=full","pubTime":"2026-08-11 01:14","pubTimestamp":1786382078,"startTime":"0","endTime":"0","summary":"投资活动产生的现金流量净额变动幅度为105.02%,原因:公司理财产品投资收回及出售部分药捷安康股票取得收益。筹资活动产生的现金流量净额变动幅度为41.57%,原因:本期偿还银行借款支付的现金较上年同期减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100001186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658347949","title":"药石科技(300725)披露2026年半年度报告,8月10日股价上涨4.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658347949","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658347949?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:01","pubTimestamp":1786370515,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘,药石科技报收于49.61元,较前一交易日上涨4.44%,最新总市值为115.99亿元。该股当日开盘48.14元,最高51.65元,最低48.14元,成交额达26.9亿元,换手率为26.66%。近日,药石科技披露2026年半年度报告。报告显示,本报告期营业收入为1,059,456,803.50元,同比增长15.19%;归属于上市公司股东的净利润为99,444,867.74元,同比增长37.17%;扣除非经常性损益后的净利润为83,888,314.42元,同比增长40.70%。经营活动产生的现金流量净额为192,349,399.22元,同比下降58.80%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000033506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658847299","title":"药石科技(300725)7月20日股东户数4.65万户,较上期增加11.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658847299","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658847299?lang=zh_cn&edition=full","pubTime":"2026-08-10 17:36","pubTimestamp":1786354616,"startTime":"0","endTime":"0","summary":"证券之星消息,近日药石科技披露,截至2026年7月20日公司股东户数为4.65万户,较6月30日增加4733.0户,增幅为11.32%。在医疗服务行业个股中,药石科技股东户数低于行业平均水平,截至7月20日,医疗服务行业平均股东户数为4.87万户。从股价来看,2026年6月30日至2026年7月20日,药石科技区间涨幅为4.78%,在此期间股东户数增加4733.0户,增幅为11.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000022739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658981652","title":"药石科技:上半年净利润9944.49万元,同比增长37.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658981652","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658981652?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:57","pubTimestamp":1786352245,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658497603","title":"药石科技新提交“ZoeCarbon”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2658497603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658497603?lang=zh_cn&edition=full","pubTime":"2026-08-10 06:55","pubTimestamp":1786316115,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示,近日南京药石科技股份有限公司新提交“ZoeCarbon”等2件商标注册申请。商标申请详情如下:今年以来南京药石科技股份有限公司新申请注册商标59件,截止目前公司共持有注册商标64件,另有75件商标尚在注册申请中。通过天眼查大数据分析,南京药石科技股份有限公司共对外投资了21家企业,参与招投标项目34次;财产线索方面有商标信息183条,专利信息157条,著作权信息5条;此外企业还拥有行政许可47个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657761615","title":"8月7日药石科技涨18.39%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657761615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657761615?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:49","pubTimestamp":1786092576,"startTime":"0","endTime":"0","summary":"证券之星消息,8月7日药石科技涨18.39%创60日新高,收盘报47.5元,换手率23.62%,成交量47.87万手,成交额21.28亿元。重仓药石科技的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657146616","title":"药石科技涨18.39%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2657146616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657146616?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:49","pubTimestamp":1786092560,"startTime":"0","endTime":"0","summary":"今日药石科技涨18.39%,收盘报47.5元。2026年7月6日,开源证券研究员余汝意发布了对药石科技的研报《公司信息更新报告:CRDMO转型稳步推进,盈利蓄力增长》,该研报对药石科技给出“买入”评级。研报中预计2026-2028年公司归母净利润为2.49/3.34/4.12亿元,EPS为1.07/1.43/1.76元,当前股价对应PE为35.0/26.2/21.2倍,公司作为国内稀缺的CRDMO一体化平台,2026Q1在手订单超20%增长锁定收入弹性,维持“买入”评级。药石科技个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657512083","title":"药石科技:将持续通过规范治理、稳健经营、提升信息披露质量和加强投资者沟通等方式,努力推动公司内在价值提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2657512083","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657512083?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:15","pubTimestamp":1785921329,"startTime":"0","endTime":"0","summary":"公司管理层将继续聚焦主营业务发展,持续推进技术平台建设、市场拓展和运营效率提升,增强公司长期竞争力和可持续发展能力。二级市场股价受多重因素影响,敬请投资者理性判断并注意投资风险。公司相关经营情况请以定期报告及公告披露内容为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500031415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657061512","title":"药石科技:始终坚持自身差异化战略定位","url":"https://stock-news.laohu8.com/highlight/detail?id=2657061512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657061512?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:15","pubTimestamp":1785921329,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技(300725)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问:公司经营状态、业务水平、治理能力等相对较差,建议公司及时跟药明康德对接,争取纳入药明康德版图,共同推进中国创新药研发端相关能力建设,让更多创新药物惠及病患。药石科技回复:投资者您好!公司始终坚持自身差异化战略定位,深耕创新医药 CDMO 主业,持续提升经营质量与核心竞争力,为全体股东创造长期价值。相关重大事项请以公司正式公告为准。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500031416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656030536","title":"药石科技涨11.16%,开源证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2656030536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656030536?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:53","pubTimestamp":1785833626,"startTime":"0","endTime":"0","summary":"今日药石科技涨11.16%,收盘报40.24元。2026年7月6日,开源证券研究员余汝意发布了对药石科技的研报《公司信息更新报告:CRDMO转型稳步推进,盈利蓄力增长》,该研报对药石科技给出“买入”评级。研报中预计2026-2028年公司归母净利润为2.49/3.34/4.12亿元,EPS为1.07/1.43/1.76元,当前股价对应PE为35.0/26.2/21.2倍,公司作为国内稀缺的CRDMO一体化平台,2026Q1在手订单超20%增长锁定收入弹性,维持“买入”评级。药石科技个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400027889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655225438","title":"7月30日药石科技跌6.06%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2655225438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655225438?lang=zh_cn&edition=full","pubTime":"2026-07-30 16:56","pubTimestamp":1785401782,"startTime":"0","endTime":"0","summary":"证券之星消息,7月30日药石科技跌6.06%,收盘报35.8元,换手率8.48%,成交量17.19万手,成交额6.28亿元。重仓药石科技的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000026326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653707508","title":"药石科技:截至2026年7月20日,公司股东人数46,538名","url":"https://stock-news.laohu8.com/highlight/detail?id=2653707508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653707508?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:18","pubTimestamp":1784881098,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技(300725)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问:最新股东人数是多少比如7月15号药石科技回复:投资者您好,截至2026年7月20日,公司股东人数46,538名。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400027051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652840674","title":"7月17日药石科技跌11.77%,信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652840674","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652840674?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:55","pubTimestamp":1784278542,"startTime":"0","endTime":"0","summary":"证券之星消息,7月17日药石科技跌11.77%,收盘报36.89元,换手率14.19%,成交量28.77万手,成交额11.05亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。信澳优享生活混合A目前规模为1.48亿元,最新净值1.0661,较上一交易日下跌4.68%,近一年下跌7.59%。信澳优享生活混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01717","BK1553","BK1597","BK1237","BK0229","300725","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651758221","title":"7月14日药石科技创60日新高,信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651758221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651758221?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:32","pubTimestamp":1784017948,"startTime":"0","endTime":"0","summary":"证券之星消息,7月14日药石科技涨6.49%创60日新高,收盘报41.0元,换手率12.37%,成交量25.07万手,成交额10.0亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。信澳优享生活混合A目前规模为1.48亿元,最新净值1.0898,较上一交易日下跌6.12%,近一年下跌3.7%。信澳优享生活混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400030888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1553","300725","BK1500","BK0229","01717","BK1597","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649499136","title":"开源证券:给予药石科技买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2649499136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649499136?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:15","pubTimestamp":1783322102,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意近期对药石科技进行研究并发布了研究报告《公司信息更新报告:CRDMO转型稳步推进,盈利蓄力增长》,给予药石科技买入评级。最新盈利预测明细如下:该股最近90天内共有1家机构给出评级,买入评级1家。本文数据来源于开源证券股份有限公司,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600014592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648612056","title":"药石科技(300725)披露调整2026年度日常关联交易预计公告,7月3日股价上涨1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648612056","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648612056?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:33","pubTimestamp":1783089198,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,药石科技报收于37.33元,较前一交易日上涨1.47%,最新总市值为87.28亿元。该股当日开盘37.28元,最高37.8元,最低36.28元,成交额达3.93亿元,换手率为5.23%。公司于近日披露《关于调整2026年度日常关联交易预计的公告》。关联交易定价参照市场价格协商确定,不存在损害公司及中小股东利益的情形。该事项在董事会审批权限内,无需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300045919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786723193674,"stockEarnings":[{"period":"1week","weight":0.3657},{"period":"1month","weight":0.3363},{"period":"3month","weight":0.4545},{"period":"6month","weight":0.3567},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.4334}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京药石科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"46538人(较上一季度增加11.32%)","perCapita":"4356股","listingDate":"2017-11-10","address":"江苏省南京市浦口区江北新区华盛路81号","registeredCapital":"23380万元","survey":" 南京药石科技股份有限公司的主营业务是提供具备类药性的创新小分子砌块。公司的主要产品是药物研究阶段的产品与服务、药物开发阶段的产品和服务、新分子实体(OPC)业务、绿色与智能技术平台。","listedPrice":11.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药石科技(300725)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药石科技(300725)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药石科技,300725,药石科技股票,药石科技股票老虎,药石科技股票老虎国际,药石科技行情,药石科技股票行情,药石科技股价,药石科技股市,药石科技股票价格,药石科技股票交易,药石科技股票购买,药石科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药石科技(300725)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药石科技(300725)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}